Literature DB >> 31559055

Comparison of costs of hospitalization of patients with primary lung cancer after lobectomy with access through classic thoracotomy and VATS in the conditions of financing based on diagnosis-related groups.

Joanna Lipińska1, Marcin Wawrzycki1, Sławomir Jabłoński1.   

Abstract

BACKGROUND: One of serious problems in the management of health care units is rational management of financial resources allocated by the government for health care. This management is significantly influenced by the valuation tariff of health care services, including surgical procedures. The assessment of the cost-effectiveness of a particular service has a key role in the selection of procedures performed in a given health care unit. The aim of the study is to assess the costs of lobectomy via thoracotomy and video-assisted thoracoscopic surgery (VATS) in terms of the impact on the overall hospitalization cost and the answer to the question whether differences in hospitalization costs depending on the access are large enough to justify different valuation tariffs for surgery via traditional and minimally invasive access.
METHODS: This is a retrospective analysis of data on the costs of treatment of patients who underwent lobectomy via traditional access or VATS due to non-small cell lung cancer. Data concerning valuation of the procedure and hospitalization were compared with general costs of hospital treatment of these patients.
RESULTS: The study has proven that duration of the procedure (VATS: 145 min, thoracotomy: 143 min) and total value of hospitalization costs depending on the type of access (VATS: €2,235, thoracotomy: €1,500) were similar-the differences did not show statistical significance (P=0.96 and 0.05118). In contrast, the average time of patient stay in the hospital after surgery and the average cost of surgery were significantly different (3.69 for VATS vs. 5.71 days for thoracotomy with P=0.0000084 and €1,705 for VATS and €682 for thoracotomy with P=0.0114).
CONCLUSIONS: The total cost of patient hospitalization after lobectomy via VATS is similar to the cost of hospitalization after thoracotomy. Similar costs of both treatments with well-known benefits of VATS including shorter hospitalization and better quality of life of the patient speak in favor of a wider use of minimally invasive access with a good effect in the form of economical use of financial resources.

Entities:  

Keywords:  Video-assisted thoracoscopic surgery lobectomy (VATS lobectomy); costs of hospitalization; diagnosis-related groups

Year:  2019        PMID: 31559055      PMCID: PMC6753414          DOI: 10.21037/jtd.2019.07.90

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  9 in total

1.  Video-assisted thoracic surgery lobectomy: can we afford it?

Authors:  Gianluca Casali; William S Walker
Journal:  Eur J Cardiothorac Surg       Date:  2009-01-10       Impact factor: 4.191

2.  Current costs of video-assisted thoracic surgery (VATS) lobectomy.

Authors:  Tunc Lacin; Scott Swanson
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

3.  Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial.

Authors:  Morten Bendixen; Ole Dan Jørgensen; Christian Kronborg; Claus Andersen; Peter Bjørn Licht
Journal:  Lancet Oncol       Date:  2016-05-06       Impact factor: 41.316

Review 4.  Modern impact of video assisted thoracic surgery.

Authors:  Rachit D Shah; Thomas A D'Amico
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

5.  Cost and effectiveness of video-assisted thoracoscopic surgery for clinical stage I non-small cell lung cancer: a population-based analysis.

Authors:  Hsin-Yuan Fang; Fei-Yuan Hsiao; Hsu-Chih Huang; Yu-Sen Lin; Chih-Yi Chen; Shwn-Huey Shieh; Pin-Ru Chen; Chein-Kuang Chen; Chun-Ru Chien
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

6.  Quality of life and survival after II stage nonsmall cell carcinoma surgery: Video-assisted thoracic surgery versus thoracotomy lobectomy.

Authors:  J Zhao; Y Zhao; T Qiu; W Jiao; Y Xuan; X Wang; Y Wang; Y Luo
Journal:  Indian J Cancer       Date:  2015-12       Impact factor: 1.224

7.  Ninety-day costs of video-assisted thoracic surgery versus open lobectomy for lung cancer.

Authors:  Farhood Farjah; Leah M Backhus; Thomas K Varghese; Michael S Mulligan; Aaron M Cheng; Rafael Alfonso-Cristancho; David R Flum; Douglas E Wood
Journal:  Ann Thorac Surg       Date:  2014-05-10       Impact factor: 4.330

8.  Cost-effectiveness analysis for clinicians.

Authors:  Suzanne R Hill
Journal:  BMC Med       Date:  2012-02-01       Impact factor: 8.775

9.  High costs as a slow down factor of thoracoscopic lobectomy development in Poland - an institutional experience.

Authors:  Cezary Piwkowski; Piotr Gabryel; Bartlomiej Gałęcki; Magdalena Roszak; Wojciech Dyszkiewicz
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2013-06-12       Impact factor: 1.195

  9 in total
  2 in total

1.  Detection of miR-155-5p and imaging lung cancer for early diagnosis: in vitro and in vivo study.

Authors:  Hai-Zhen Zhu; Chun-Ju Fang; Yi Guo; Qi Zhang; Li-Min Huang; Dong Qiu; Guang-Peng Chen; Xiu-Feng Pang; Jian-Jun Hu; Jian-Guo Sun; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2020-05-23       Impact factor: 4.553

2.  Is video-assisted thoracoscopic lobectomy associated with higher overall costs compared with open surgery? Results of best evidence topic analysis.

Authors:  Alfonso Fiorelli; Stefano Forte; Francesco Paolo Caronia; Francesco Ferrigno; Mario Santini; René Horsleben Petersen; Wentao Fang
Journal:  Thorac Cancer       Date:  2021-02-05       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.